Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hospital-Acquired Disease Testing market report explains the definition, types, applications, major countries, and major players of the Hospital-Acquired Disease Testing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Nordion
Gen-Probe
Meridian Biosciences
F Hoffmann-La Roche
Cepheid
Diatherix Laboratories
Cantel Medical Corporation
Qiagen
Life Technologies Corporation
By Type:
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing
By End-User:
Small and Medium Sized Hospitals
Large Sized Hospitals
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Hospital-Acquired Disease Testing Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Hospital-Acquired Disease Testing Outlook to 2028- Original Forecasts
-
2.2 Hospital-Acquired Disease Testing Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Hospital-Acquired Disease Testing Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Hospital-Acquired Disease Testing Market- Recent Developments
-
6.1 Hospital-Acquired Disease Testing Market News and Developments
-
6.2 Hospital-Acquired Disease Testing Market Deals Landscape
7 Hospital-Acquired Disease Testing Raw Materials and Cost Structure Analysis
-
7.1 Hospital-Acquired Disease Testing Key Raw Materials
-
7.2 Hospital-Acquired Disease Testing Price Trend of Key Raw Materials
-
7.3 Hospital-Acquired Disease Testing Key Suppliers of Raw Materials
-
7.4 Hospital-Acquired Disease Testing Market Concentration Rate of Raw Materials
-
7.5 Hospital-Acquired Disease Testing Cost Structure Analysis
-
7.5.1 Hospital-Acquired Disease Testing Raw Materials Analysis
-
7.5.2 Hospital-Acquired Disease Testing Labor Cost Analysis
-
7.5.3 Hospital-Acquired Disease Testing Manufacturing Expenses Analysis
8 Global Hospital-Acquired Disease Testing Import and Export Analysis (Top 10 Countries)
-
8.1 Global Hospital-Acquired Disease Testing Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Hospital-Acquired Disease Testing Export by Region (Top 10 Countries) (2017-2028)
9 Global Hospital-Acquired Disease Testing Market Outlook by Types and Applications to 2022
-
9.1 Global Hospital-Acquired Disease Testing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global UTI Testing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global SSI Testing Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pneumococcal Infections Testing Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Bloodstream Infections Testing Consumption and Growth Rate (2017-2022)
-
9.1.5 Global MRSA Testing Consumption and Growth Rate (2017-2022)
-
9.2 Global Hospital-Acquired Disease Testing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Small and Medium Sized Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Large Sized Hospitals Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Hospital-Acquired Disease Testing Market Analysis and Outlook till 2022
-
10.1 Global Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.2.2 Canada Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.2.3 Mexico Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.2 UK Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.3 Spain Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.4 Belgium Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.5 France Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.6 Italy Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.7 Denmark Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.8 Finland Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.9 Norway Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.10 Sweden Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.11 Poland Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.12 Russia Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.3.13 Turkey Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.2 Japan Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.3 India Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.4 South Korea Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.5 Pakistan Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.6 Bangladesh Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.7 Indonesia Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.8 Thailand Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.9 Singapore Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.10 Malaysia Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.11 Philippines Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.4.12 Vietnam Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.5.2 Colombia Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.5.3 Chile Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.5.4 Argentina Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.5.5 Venezuela Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.5.6 Peru Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.5.7 Puerto Rico Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.5.8 Ecuador Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.6.2 Kuwait Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.6.3 Oman Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.6.4 Qatar Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.6.5 Saudi Arabia Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.6.6 United Arab Emirates Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.7.2 South Africa Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.7.3 Egypt Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.7.4 Algeria Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Hospital-Acquired Disease Testing Consumption (2017-2022)
-
10.8.2 New Zealand Hospital-Acquired Disease Testing Consumption (2017-2022)
11 Global Hospital-Acquired Disease Testing Competitive Analysis
-
11.1 Nordion
-
11.1.1 Nordion Company Details
-
11.1.2 Nordion Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Nordion Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.1.4 Nordion Hospital-Acquired Disease Testing Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Gen-Probe
-
11.2.1 Gen-Probe Company Details
-
11.2.2 Gen-Probe Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.2.4 Gen-Probe Hospital-Acquired Disease Testing Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Meridian Biosciences
-
11.3.1 Meridian Biosciences Company Details
-
11.3.2 Meridian Biosciences Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Meridian Biosciences Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.3.4 Meridian Biosciences Hospital-Acquired Disease Testing Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 F Hoffmann-La Roche
-
11.4.1 F Hoffmann-La Roche Company Details
-
11.4.2 F Hoffmann-La Roche Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 F Hoffmann-La Roche Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.4.4 F Hoffmann-La Roche Hospital-Acquired Disease Testing Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Cepheid
-
11.5.1 Cepheid Company Details
-
11.5.2 Cepheid Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Cepheid Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.5.4 Cepheid Hospital-Acquired Disease Testing Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Diatherix Laboratories
-
11.6.1 Diatherix Laboratories Company Details
-
11.6.2 Diatherix Laboratories Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Diatherix Laboratories Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.6.4 Diatherix Laboratories Hospital-Acquired Disease Testing Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Cantel Medical Corporation
-
11.7.1 Cantel Medical Corporation Company Details
-
11.7.2 Cantel Medical Corporation Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.7.4 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Qiagen
-
11.8.1 Qiagen Company Details
-
11.8.2 Qiagen Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Qiagen Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.8.4 Qiagen Hospital-Acquired Disease Testing Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Life Technologies Corporation
-
11.9.1 Life Technologies Corporation Company Details
-
11.9.2 Life Technologies Corporation Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Life Technologies Corporation Hospital-Acquired Disease Testing Main Business and Markets Served
-
11.9.4 Life Technologies Corporation Hospital-Acquired Disease Testing Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Hospital-Acquired Disease Testing Market Outlook by Types and Applications to 2028
-
12.1 Global Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global UTI Testing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global SSI Testing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Pneumococcal Infections Testing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Bloodstream Infections Testing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global MRSA Testing Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Small and Medium Sized Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Large Sized Hospitals Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Hospital-Acquired Disease Testing Market Analysis and Outlook to 2028
-
13.1 Global Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.2.2 Canada Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.2.3 Mexico Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.2 UK Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.3 Spain Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.4 Belgium Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.5 France Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.6 Italy Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.7 Denmark Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.8 Finland Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.9 Norway Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.10 Sweden Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.11 Poland Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.12 Russia Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.3.13 Turkey Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.2 Japan Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.3 India Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.4 South Korea Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.8 Thailand Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.9 Singapore Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.11 Philippines Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.5.2 Colombia Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.5.3 Chile Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.5.4 Argentina Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.5.6 Peru Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.6.3 Oman Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.6.4 Qatar Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.7.2 South Africa Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.7.3 Egypt Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.7.4 Algeria Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Hospital-Acquired Disease Testing Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Hospital-Acquired Disease Testing
-
Figure of Hospital-Acquired Disease Testing Picture
-
Table Global Hospital-Acquired Disease Testing Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Hospital-Acquired Disease Testing Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global UTI Testing Consumption and Growth Rate (2017-2022)
-
Figure Global SSI Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumococcal Infections Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Bloodstream Infections Testing Consumption and Growth Rate (2017-2022)
-
Figure Global MRSA Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Small and Medium Sized Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Large Sized Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital-Acquired Disease Testing Consumption by Country (2017-2022)
-
Table North America Hospital-Acquired Disease Testing Consumption by Country (2017-2022)
-
Figure United States Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Canada Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Mexico Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Table Europe Hospital-Acquired Disease Testing Consumption by Country (2017-2022)
-
Figure Germany Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure UK Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Spain Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Belgium Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure France Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Italy Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Denmark Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Finland Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Norway Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Sweden Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Poland Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Russia Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Turkey Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Table APAC Hospital-Acquired Disease Testing Consumption by Country (2017-2022)
-
Figure China Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Japan Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure India Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Thailand Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Singapore Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Philippines Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Table South America Hospital-Acquired Disease Testing Consumption by Country (2017-2022)
-
Figure Brazil Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Colombia Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Chile Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Argentina Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Peru Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Table GCC Hospital-Acquired Disease Testing Consumption by Country (2017-2022)
-
Figure Bahrain Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Oman Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Qatar Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Table Africa Hospital-Acquired Disease Testing Consumption by Country (2017-2022)
-
Figure Nigeria Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure South Africa Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Egypt Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure Algeria Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Table Oceania Hospital-Acquired Disease Testing Consumption by Country (2017-2022)
-
Figure Australia Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Hospital-Acquired Disease Testing Consumption and Growth Rate (2017-2022)
-
Table Nordion Company Details
-
Table Nordion Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table Nordion Hospital-Acquired Disease Testing Product Portfolio
-
Table Gen-Probe Company Details
-
Table Gen-Probe Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gen-Probe Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table Gen-Probe Hospital-Acquired Disease Testing Product Portfolio
-
Table Meridian Biosciences Company Details
-
Table Meridian Biosciences Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meridian Biosciences Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table Meridian Biosciences Hospital-Acquired Disease Testing Product Portfolio
-
Table F Hoffmann-La Roche Company Details
-
Table F Hoffmann-La Roche Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table F Hoffmann-La Roche Hospital-Acquired Disease Testing Product Portfolio
-
Table Cepheid Company Details
-
Table Cepheid Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cepheid Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table Cepheid Hospital-Acquired Disease Testing Product Portfolio
-
Table Diatherix Laboratories Company Details
-
Table Diatherix Laboratories Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Diatherix Laboratories Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table Diatherix Laboratories Hospital-Acquired Disease Testing Product Portfolio
-
Table Cantel Medical Corporation Company Details
-
Table Cantel Medical Corporation Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cantel Medical Corporation Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table Cantel Medical Corporation Hospital-Acquired Disease Testing Product Portfolio
-
Table Qiagen Company Details
-
Table Qiagen Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table Qiagen Hospital-Acquired Disease Testing Product Portfolio
-
Table Life Technologies Corporation Company Details
-
Table Life Technologies Corporation Hospital-Acquired Disease Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Life Technologies Corporation Hospital-Acquired Disease Testing Main Business and Markets Served
-
Table Life Technologies Corporation Hospital-Acquired Disease Testing Product Portfolio
-
Figure Global UTI Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SSI Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumococcal Infections Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bloodstream Infections Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MRSA Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small and Medium Sized Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Large Sized Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital-Acquired Disease Testing Consumption Forecast by Country (2022-2028)
-
Table North America Hospital-Acquired Disease Testing Consumption Forecast by Country (2022-2028)
-
Figure United States Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hospital-Acquired Disease Testing Consumption Forecast by Country (2022-2028)
-
Figure Germany Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Hospital-Acquired Disease Testing Consumption Forecast by Country (2022-2028)
-
Figure China Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Hospital-Acquired Disease Testing Consumption Forecast by Country (2022-2028)
-
Figure Brazil Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Hospital-Acquired Disease Testing Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Hospital-Acquired Disease Testing Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Hospital-Acquired Disease Testing Consumption Forecast by Country (2022-2028)
-
Figure Australia Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Hospital-Acquired Disease Testing Consumption Forecast and Growth Rate (2022-2028)
-
